Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.
about
Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells.Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity.Increased sensitivity to staphylococcal enterotoxin B following adenoviral infectionThe influence of delivery vectors on HIV vaccine efficacyT cell intrinsic NOD2 is dispensable for CD8 T cell immunityThe HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccinesUse of adenoviral vectors as veterinary vaccines.T-cell immunity generated by recombinant adenovirus vaccines.Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccinesPersistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus.Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in CattleVirus-induced hepatocellular carcinomas cause antigen-specific local tolerance.Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination.High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome.Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR.The antimicrobial/elastase inhibitor elafin regulates lung dendritic cells and adaptive immunity.Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.Firewalls Prevent Systemic Dissemination of Vectors Derived from Human Adenovirus Type 5 and Suppress Production of Transgene-Encoded Antigen in a Murine Model of Oral Vaccination.Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8⁺ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice.
P2860
Q33591529-D480165A-9A92-4189-A88B-FFF850676ECAQ33713903-FD408E41-0221-45E7-8A77-E82E3A7F6A35Q33788137-AFD2DC05-F73A-420E-9271-1C50FD431C11Q34077543-9D8CE557-03C9-478D-8D8D-883482434E1CQ34584661-BDF6C7C1-6D3B-4C9F-8335-090856575B78Q35040673-B6054DA6-D40B-4AC6-8E30-B9EA42478865Q35876220-EC6A5361-0161-469D-93E9-EA62FB1A85B5Q36288927-CE037A89-8060-4306-B951-82717D8F6FE5Q36837129-1FB3A0AA-29FA-4C7B-9AFC-4C747B9B1096Q37066228-5655BE61-282D-48FC-9B9D-E94D25C5685AQ37189696-E26A9C8A-9C6B-481F-B817-A48B89E04C10Q37196054-382DB1B9-F1F3-4FB1-A421-7D187DC5F7A9Q37452136-17ADF7C1-EA8E-4862-8507-807DAA28021DQ37603360-B79037ED-1686-4148-AC20-F9C5BB23000DQ37932525-DFA39E89-21C3-42D2-9042-CF8C333BE472Q38280242-AFF3B367-E502-42B9-847E-BB2FC6C8F39FQ39186289-D03B523D-90A3-4959-8391-7CE85F140AA8Q39763165-D7C6AE92-6184-4706-BE18-2D7A076E6BBCQ39920459-E413437C-7BF5-4F5C-BEF2-6FB332BBAC7CQ41995734-A76CE75C-D1B5-499C-87B6-79BB0BD74519Q43687460-A115354D-DDE9-40CB-9E8B-B009D3FC28C6Q44106019-C27EED48-19A6-429E-A2CA-85E48B0B6DB4Q45324559-740E521E-8410-4CD1-AC11-922C03840A7CQ49167770-D30E7604-6562-4841-9DE6-809835572888Q51888314-EC3D2ACE-EBBC-49D1-92A5-545BDE9B1807Q53248364-8ABB002A-77EB-40AD-90F6-318B9564E373
P2860
Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.
@en
type
label
Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.
@en
prefLabel
Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.
@en
P2093
P2860
P1433
P1476
Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.
@en
P2093
Kelley Dayball
Teng Chih Yang
Yong Hong Wan
P2860
P304
13407-13411
P356
10.1128/JVI.77.24.13407-13411.2003
P407
P577
2003-12-01T00:00:00Z